MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, LIXTW had $1,848,922 increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$1,848,922
Unit: Dollar
Positive Cash Flow Breakdown
    • Proceeds from sale of securities...
    • Proceeds from sale of securities...
    • General and administrative costs
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Purchase of digital assets
    • Prepaid insurance

Cash Flow
2025-09-30
Net loss
-3,465,626
General and administrative costs
1,144,348
Common stock issued for services
44,711
Unrealized gain (loss) on digital assets
-182,887
Prepaid insurance
8,592
Other prepaid expenses
-23,814
Accounts payable and accrued expenses
95,661
Research and development contract liabilities
77
Net cash used in operating activities
-1,982,720
Purchase of digital assets
2,637,360
Net cash used in investing activities
-2,637,360
Proceeds from sale of securities in registered direct offerings, net of offering costs
2,245,040
Proceeds from sale of securities in registered private placement, net of offering costs
4,178,162
Exercise of common stock warrants
45,800
Net cash provided by financing activities
6,469,002
Net increase (decrease)
1,848,922
Cash and cash equivalents at beginning of period
1,038,952
Cash and cash equivalents at end of period
2,887,874
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from sale ofsecurities in registered...$4,178,162 Proceeds from sale ofsecurities in registered...$2,245,040 Exercise of common stockwarrants$45,800 Net cash provided byfinancing activities$6,469,002 Net increase(decrease)$1,848,922 Canceled cashflow$4,620,080 General andadministrative costs$1,144,348 Unrealized gain (loss) ondigital assets-$182,887 Accounts payable andaccrued expenses$95,661 Common stock issued forservices$44,711 Other prepaidexpenses-$23,814 Research and developmentcontract liabilities$77 Net cash used ininvesting activities-$2,637,360 Net cash used inoperating activities-$1,982,720 Canceled cashflow$1,491,498 Purchase of digitalassets$2,637,360 Net loss-$3,465,626 Prepaid insurance$8,592

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXTW)

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXTW)